Moderna’s Shift to Cancer Company Lifts Stock Up 177%
Global - North America
Archived
•
August 20, 2026
•
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Source: NYT Home Page | https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!


